[1]
Bonadio, R.C. et al. 2026. Grade 1 hormone receptor-positive early breast cancer: is Oncotype DX necessary?. Mastology. 35, suppl.1 (Feb. 2026). DOI:https://doi.org/10.29289/259453942025V35S1031.